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Historically, and at present, carbon monoxide is a major gaseous poison responsible for widespread
morbidity and mortality. From threshold to maximal nonlethal levels, avariety ofcardiovascular changes
occur, both immediately and in the long term, whose homeostatic function it is to renormalize tissue
oxygen delivery. However, notwithstanding numerous studies overthe past century, the literatureremains
equivocal regarding the hemodynamic responses in animals and humans, although CO hypoxia is clearly
different in several respects from hypoxic hypoxia. Factors complicating interpretation of experimental
findings include species, CO dose level and rate, route ofCO delivery, duration, level ofexertion, state of
consciousness, and anesthetic agent used. For example, tachycardia is commonly observed, although
bradycardia also can result from myocardial and/or central nervous system (CNS) hypoxemia at high
carboxyhemoglobin (COHb) saturations, as can electrocardiographic abnormalities. Augmented cardiac
output usually observed with moderate COHb may be compromised in more severe poisoning for the same
reasons, such that regional orglobal ischemia result. The hypotension usually seen in most animal studies
is thought to be a primary cause of CNS damage resulting from acute CO poisoning, yet the exact
mechanism(s) remains unproven in both animals and humans, as does the way in which CO produces
hypotension. This review briefly summarizes the literature relevant to the short- and long-term hemo-
dynamic responses reported in animals and humans. It concludes by presenting an overview using data
from a single species in which the most complete work has been done to date.
Introduction
The lethal constituent of the fumes of burning fossil
fuels was not identified as carbon monoxide (CO) until
the beginning of the 19th century (1). Claude Bernard
(2) and John Scott Haldane (3) were among the first to
investigate the cardiorespiratory and psychological ef-
fects of CO. The recent book by Pankow (4) broadly
reviews the toxicology of CO, and articles by Ginsberg
(5), Turino (6), and McGrath (7) have discussed limited
areas of its action.
Forbes et al. (8) demonstrated the dependence ofcar-
boxyhemoglobin (COHb) saturation on ventilation rate,
inhalation time, and percentage of inspired CO. More
recently, Peterson and Stewart (9) and Joumard et al.
(10) presented refinements in predicting COHb levels
in humans, while Tyuma et al. (11) have done the same
for several animal species. In general, CO uptake to an
equilibrium COHb saturation is slow in large species
such as humans and requires 8 to 24 hr; only 1 to 2 hr
are necessary in small species such as rats (12).
Hemodynamic changes permit a rapid response to
depressedblood oxygencarryingcapacity; however, the
hemodynamics may be altered during sustained chal-
lenge. This review summarizes such responses to CO
derived from human and animal experiments. As far as
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the author is aware, this is the first time this aspect of
CO toxicity has been summarized in depth.
Studying the responses ofa system to a challenge in
isolation from one another may result in failure to ap-
preciateinteractions amongtheresponses. Bearingthis
limitation in mind, the various cardiovascular parame-
terswillnonethelessbeconsidered oneatatimeinorder
to compare and contrasthowtheyareinfluencedbyCO.
Acute studies are considered first, then chronic; animal
studies precede human, and where possible, data from
the awake statefollowthose obtainedunderanesthesia.
Abriefsummaryandintegrationofresponsesconcludes
each of the sections. This seems a manageable way in
which to proceed considering the nonuniformity of ex-
perimentalapproaches in the literature, withrespectto
species, CO dose level, CO dose rate, route of CO de-
livery, study duration, rest or exercise, state of con-
sciousness, and anesthetic agentused. Because pulse or
heartrate (HR) is labile, easily measured, and has been
examined in so many studies, it is discussed first.
Heart Rate
Acute
Anesthetized Animals. In 1921, Haggard (13) ob-
servedincreasesinheartrate(HR)withCOHbbetween
16 and 20% in dogs; Chiodi (14) reported that HR in-
creased sharply in dogs as COHb approached 50%. Kil-D. G. PENNEY
lick (15), however, foundlittle change inHRuntil COHb
reached 25 to 30%, after which it increased approxi-
matelyinproportion to COHb. Marked tachycardiawas
notedbyEinzigetal. (16) atCOHb saturations between
26.5 and 41.6% in dogs, declining as CO disappeared.
Ayres et al. (17) reported modest tachycardia in dogs
inhaling CO, while Lillehei et al. (18) saw a rise in HR
over 30 min in nembutalized dogs. Dogs were found to
be more resistant to carboxyhemoglobinemia than hu-
mans by the Ayres group (17), responding with in-
creased HR only at higher COHb.
Using chloralose-urethan anesthetized rats, Kanten
et al. (19) saw modest increases in HR at 7 to 40%
COHb. However, tachycardia was more prominent in
the conscious state in this study, especially during the
first fewhours ofcarboxyhemoglobinemia. Onthe other
hand, even at high COHb (40%), HR was variable in
nembutalized rats (20) and anesthetized paralyzed dogs
(21). King et al. (22) saw no change in HR at 50 to 65%
COHb, but it is significant that the control dogs had
HRs of 186 and 196 bpm because ofthe anesthetic (i.e.,
pentobarbital).
Anesthesia-induced tachycardia was also present in
the study of Gutierrez et al. (23), but 50% COHb pro-
voked some further increase in HR. According to Nor-
man et al. (24), HR did not vary in a consistent manner
with COHb saturation overthe range 0to 70% inlightly
anesthetized dogs inhaling coal gas. Progressive sinus
bradycardia and eventual cardiac standstill which was
correctable by pacemaker were seen by Dergal et al.
(25) in anesthetized dogs inhaling 2 to 10% CO.
Pindok et al. (26) saw increased HR in anesthetized
dogs inhaling smoke containing 1.6% CO generated by
burning charcoal and sawdust. While COHb reached
72% after 8 min, the smoke constitutents produced hy-
poxic hypoxia and hypercapnia as well as CO hypoxia.
Conscious Animals. HR was seen to increase sev-
eralfoldbySantiago and Edelman(27)ingoats asCOHb
approached 60%. Adams et al. (28) reported a 4% in-
crease in HR in dogs at 4% COHb, with HR increasing
by20% at 20% COHb. In dogs attaining 10, 20, and 30%
COHb by brief CO inhalation, Cramlet et al. (29) saw
17.6, 35.7, and 55.7% increases in HR, respectively;
while in anotherstudy (30), HR rose 18% in awake dogs
brieflyattaining30% COHb. Tachyeardiawasalsonoted
in both conscious and de-efferented rabbits inhaling
0.2% CO (31,32).
Petajanandhiscolleagues (33)foundthatatveryhigh
COHb (65-70%), HR was severely depressed in con-
scious rats inhaling 1500 ppm CO for 80 min, although
HR rose transiently upon initial exposure.
Adams et al. (28) found that HR did not increase
during exposure to CO following administration ofpro-
pranolol and suggested that tachyeardia is a 3-adre-
nergic response mediated through the sympathetic ner-
vous system. According to Ayres et al. (34), low to
moderate CO levels in resting subjects may not initiate
increased sympathetic activity. It is unclear, however,
whetherthetransient catecholamine releasethat occurs
with carboxyhemoglobinemia (21,35,36) contributes to
cardiac speeding. Inhemoglobin-free rabbitstransfused
with perfluorochemical emulsions, even 5, 10, and 20%
CO in the inspired gas mixture fails to alter HR (37),
which rules out a direct chronotropic effect of CO.
Humans. Chiodi (14) reported that HR increased
sharply in men as COHb approached 50%. Sinus tachy-
cardia, T-wave abnormalities, and other electrocardi-
ographic changes were seen by Cosby and Bergeron
(38)inpatientswithCOpoisoning, butbloodlevelswere
not given. While Stewart et al. (39) established a direct
correlation between COHb saturation and cardiac out-
put in the range 0 to 15% in healthy humans, no change
in HR was seen.
Nielsen (40), examining the effects of CO on human
thermoregulation, observed HR increases at 25 to 33%
COHb. Lazarev (41) has also noted cardiac acceleration
both in cases of acute and chronic CO exposure in hu-
mans.
In contrast, Shephard (42) reported no change in HR
in humans during 30 min of laboratory work at 2.4 to
5.4% COHb. Vogel and Gleser (43) also failed to see
tachycardia in resting humans at 18 to 20% COHb, al-
though HR at several submaximal exercise levels was
greater than when not breathing CO. This was con-
firmed in a second study by the same group (44) and
closely resembled the responses to hypoxic hypoxia.
During moderate exercise in humans at 15% COHb,
Pirnay et al. (45) found HR was 11.4% higher than nor-
mal. In two groups ofmen, one inhaling 50 ppm CO and
another 100 ppm CO and working at 35% of maximal
oxygen consumption rate, HR was higher than in air
controls similarly working (46). Strangely, Chevalier et
al. (47) found HR was lower in nonsmoking men at rest
who inhaled CO after 2 and 5 min ofexercise and 3 min
following exercise.
Chronic
Animals. AsmussenandVinther-Paulsen (48) found
that heart rate in the dog was double control values
during 10 days at 46% COHb. When CO exposure is
prolonged beyond a few days or weeks, compensatory
processes such as polycythemia, hypervolemia, and car-
diomegalymay supervene depending upon COHb level,
which alter the subsequent hemodynamic picture (Fig.
1). Significant increases in hemoglobin concentration
have been observed in chronic studies (49-52). HR was
unchanged in conscious goats maintained at 20% COHb
for 2 weeks, although there was significant bradycardia
postexposure (52). During 8 months at 11.2% COHb,
no change in HR was noted in Cynomolgus monkeys
(53). Likewise, in rats and mice exposed to 50 ppm CO
for 650 days, no change in HR was noted based on ECG
tracings (54). In dogs gradually acclimated to inhaling
1000 ppm CO for 6 to 8 hr each day for a year, HR was
found to be lower (18). Similarly, HR was slightly de-
pressed in rabbits exposed to 100 ppm CO for 2500 hr
(55).
Humans. Klausen et al. (56) found no significant
change in HR over 8 days in men resting at 12.5%
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FIGURE 1. Changes in blood volume (BV), hematocrit (Hct), heart
weight (2V), cardiac index (DI), strokeindex (SI), heartrate(HR),
carboxyhemoglobin saturation (COHb), systemic peripheral re-
sistance (R.), and arterial systolic blood pressure (BP) during 6
weeks' inhalation of 500 ppm carbon monoxide in the rat.
COHb. When the same men worked, HR rose relative
to working men not breathing CO, in a fashion similar
to acute studies. Again, this points out the limitations
ofexamining hemodynamic responses to CO only in the
resting state.
Mechanism ofCO Toxicity. Since the last century,
the question has remained whether binding to hemo-
globin and subsequent compromise ofblood oxygen car-
rying capacity constitutes CO's real mechanism of tox-
icity. In the 1940s, Drabkin et al. (57) noted that 75%
COHb acutely produced in dogs by blood replacement
results in none ofthe characteristic signs ofanoxia (e.g.,
myocardial and cerebral necrosis) seen in dogs which
inhale CO to that level of saturation. Similar experi-
ments with like results were repeated by Ramirez et
al. (58) and Goldbaum et al. (59). These investigators
maintain (a) that it is the CO dissolved in the plasma
that results in its toxic effects, not that attached to
hemoglobin, and (b) that diffusion of CO to the cells
causes its primary toxic action, possibly by binding to
cytochrome oxidase, myoglobin, etc. Intheirview, shed
blood reacted with CO and reinfused loses its dissolved
CO on one transit of the lungs and is thus much less
toxic than when CO is inspired, which results in higher
levels of dissolved CO. Intraperitoneal uptake of 100%
CO by dogs is also claimed to be nontoxic by these
investigators (61), for the same reasons. Others (62)
failed to see changes in HR in rats given CO by IP
injection. Coburn (60), among others, has criticized
these experiments based on the mode of CO inhalation
used for comparison, namely anesthetized dogs breath-
ing 13% CO: To wit, such a high concentration of CO
would be expected to saturate blood leaving the lung,
resulting in lethal neurologic and myocardial sequelae,
which, however, do not occurifuptake to the same final
COHb saturation is achieved by inhalation oflower CO
concentrations over longer time intervals.
D On the other hand, IP injection of CO into dogs by
Wilks (63) increased HR slightly, and Kanten and his
0 collaborators (19) found the same degree oftachycardia
following CO injection that occurs with equivalent
COHb saturation produced by inhalation. Likewise, in
5 dogs either ventilated or injected with CO, the same
cardiovascular responses were recorded (23). Finally,
Halebian et al. (64) found no difference in whole body
oxygen consumption in dogs ventilated with either CO
orN2 andthatreached the same arterial oxyhemoglobin
saturation, suggesting CO was not significantly inhib-
iting mitochondrial oxidative metabolism. Although the
evidence that CO toxicity results from bindingto hemo-
globinis somewhatindirect, includingthe known effects
of CO on oxygen carrying capacity and the oxyhemo-
globin dissociation curve and demonstration of small
decreases in tissue PO resultingfrom increases in blood
COHb, the evidence Tor major direct effects of CO at
the tissue level is equivocal, and the burden of proof
remains with those who propose it.
Stroke Volume
As the codeterminant of cardiac output with HR,
stroke volume (SV) or stroke index (SI) have not been
seen to consistently increase in response to CO in the
few studies in which it has been measured. Sylvester
and his colleagues (21) reported an increase over 15 to
20 min in anesthetized paralyzed dogs under constant
ventilation. King et al. (22) also saw substantial in-
creases in SV in anesthetized dogs at 50 to 65% COHb.
In anesthetized dogs receiving CO by IP injection
(COHb > 50%), SV increased more than 40% (23).
SI was increased sharply under pentobarbital anes-
thesia in rats that had been maintained at 38 to 42%
COHb for 6 weeks by CO inhalation (20). SV also in-
creased steadily in anesthetized rats studied over 48 hr
in which COHb was raised from 7 to 38% (19).
Ontheotherhand, Cramlet etal. (29) found nochange
in SV in conscious dogs at 10, 20, and 30% COHb. Like-
wise, SV was unchanged in conscious goats maintained
at 20% COHb for 2 weeks (52). However, Asmussen
and Vinther-Paulsen (48) found that SV fell substan-
tially in awake dogs at COHb values as high as 46%
during 10 days.
In humans, SV was noted to increase directly as
COHb increased from 0 to 15% (39). In contrast, Vogel
and Gleser (43) found no change in SV in humans with
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18 to 20% COHb, at rest, and even at three levels of
bicycle exercise. In resting men at 12.5% COHb for 8
days, SV was unchanged (56), however, when the same
men worked, SV fell relative to men working but not
breathing CO.
Inachronicstudy, Dhindsaand Ochsner(53)reported
no change in SV in Cynomolgus monkeys maintained at
11.2% COHb for 8 months.
Thus, SV may or may not increase in resting dogs,
goats, monkeys, and humans at low to moderate COHb
saturation, but sharply increases in rats at substantial
COHb levels. What occurs is probably related to
changes in peripheral resistance (i.e., afterload) and
venous return (i.e., preload), and whether HR changes,
such that total flow is commensurate with adequate tis-
sue oxygen delivery. During exercise or at high COHb
saturation, SV falls in dogs and humans, probably due
to myocardial hypoxemia.
Cardiac Output
Acute
In rats monitored under chloralose-urethan anes-
thesia, cardiac output (Q) was observed to increase al-
most directly with increasing COHb saturation from 7
to38% over48hr(19). Sylvesteret al. (21) alsoreported
an increased in Q over a 15- to 20-min period in anes-
thetized paralyzed dogs inhaling CO. Ayres and his
group (17), however, saw only small initial increases in
Q in dogs inhaling CO.
More recently, Gutierrez et al. (23) reported large
(35-50%) increases in Q in anesthetized dogs given CO
by inhalation or IP injection. Comparable and even
greater increases in Q were found by King et al. (66)
and King et al. (22), respectively, using similar dog
preparations in which COHb reached above 50%. Using
surgically denervated dogs, they showed that aortic
chemoreceptor input is not necessary for this increase
in Q, nor for the diversion of this increased flow to
nonmuscle tissues (66).
Chiodi and co-workers (14) found no more than slight
increases in Q in conscious dogs as COHb ranged up to
30%, while Q increased by as much as half at COHb
near 50%. No change in Q occurred in conscious dogs
brought to 10, 20, and 30% COHb within 30 min (29).
Using human subjects, Asmussen and Chiodi (67)
found only a slight increase in Q at COHb up to 33%;
however, in other conscious human studies, Chiodi et
al. (14) reported sharp increases in Q as COHb reached
as high as 48%. In patients briefly exposed to 5% CO
in air, Ayres et al. (34) found 10% increases in Q, while
Stewart etal. (39)establishedtheaforementioned direct
correlation between COHb and Q in humans over the
range 0 to 15% COHb.
On the other hand, Ayres and his group in an early
study (68) found no change in Q in humans with 4.95 to
9.69% COHb. Similarly, Vogel and Gleser (43) saw no
change in Q in resting humans at 18 to 20% COHb.
However, they did find Q was greater at equal levels
of submaximal exercise than in air controls.
Chronic
Regardinglong-term CO exposure, Penney etal. (20)
observed that Q increased sharply upon initial CO ex-
posure and remained elevated for 42 days in rats ex-
amined under anesthesia where COHb was 38 to 42%.
On the other hand, Asmussen and Vinther-Paulsen (48)
saw at maximum, a 15.8% increase in Q in conscious
dogsduring 10daysatCOHb ashighas46%. Moreover,
at20%COHb, cardiacindexwasunchangedinconscious
goats over a period of 2 weeks (52). Finally, Dhindsa
and Ochsner (53) saw no change in Q or cardiac index
in Cynomologus monkeys maintained at 11.2% COHb
for 8 months.
In men at rest who were maintained at an average
of12.5% COHb for 8 days, Q did not change (56). When
the menworked, thisparameterremained steadyorfell
relative to working men not breathing CO.
With a few exceptions (58,59,61), most investigators
agree that CO exerts its morbid effect by reversibly
binding with hemoglobin and decreasing oxygen-car-
rying capacity. It also increases the affinity of the re-
maining hemoglobin sites for oxygen, thus holding oxy-
gen more tenaciously. Both phenomena contribute to
tissue hypoxemia unless offset by increased tissue per-
fusion. Augmented Q, when it occurs, may be accom-
plished by increased HR, increased SV, or both. In
general, Q usually increases above 20% COHb unless
there is excessive myocardial hypoxemia and at lower
COHb levels with physical exercise; however, the man-
ner in which it occurs is variable; in some species or
situations it involves tachyeardia to a greater degree
than SV, and vice versa.
Blood Pressure
Acute
Anesthetized Animals. Early on several investi-
gatorsnoted theloweringofblood pressure (BP) during
acute and chronic CO inhalation (65). Brewer(69), using
pentobarbital-treated dogs, also reported hypotension.
Norman et al. (24) noted that aortic BP tended to fall
as COHb increased from 0 to 70% in dogs. MacMillan
(70) ventilated lightly anesthetized and paralyzed rats
with 1% COover60mininexaminingcerebralmetabolic
events. Mean arterial BP fell steeply at first and more
gradually afterward.
In rats briefly exposed to 2000 and 4000 ppm CO,
mean arterial BP fell at 40, 50, and 60% COHb (71).
This involved decreases in both systolic and diastolic
BP, but the latter was more pronounced, increasing
pulse pressure. Kanten et al. (19) observed profound
decreases in arterial BP, left venticular systolic pres-
sure, and total systemic peripheral resistance (TPR) in
rats over 48 hr as COHb rose from 7% to 35-38%. In
this study, BP also declined inrats IPinjectedwith CO,
where COHb reached 56% after 1 hr. Most recently,
King and his colleagues (22,65) also observed large de-
creases in mean arterial BP and TPR in unconscious
dogs at 50 to 65% COHb. However, they noted that
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hindlimb blood flow remained unchanged although Q
increased. Blood flow increased when the hindlimb was
denervated. This suggests that Q is directed to non-
muscle areas ofthe body in the presence of COHb and
that intact sympathetic innervation is required to
achieve this redistribution.
Conscious Animals. Hypotension has also been re-
ported in rabbits inhaling 0.2% CO for less than 1 hr;
arterial BP and TPR fell (31,32). In rabbits at 28%
COHb, Kleinert et al. (72) also saw a decline in arterial
BP. Usinggoatsat45to55% COHb, Santiago and Edel-
man (27) reported a decrease in diastolic arterial BP,
but no consistent change in systolic BP.
Decreased BP was also noted in conscious rats whose
COHb reached 65 to 70% after 80 min (33). This was
correlated with impaired neurological function, such as
decreased nerve conduction velocity. Okeda et al. (73)
believe that the hypotension accompanying carboxy-
hemoglobinemia is the primary causative factor in CO-
induced encephalopathy. Even in rabbits lacking hemo-
globin, arterial BP fell markedly during inhalation of5,
10, and 20% CO (37).
Traystman and Fitzgerald (74) found that cerebral
vascular resistance decreased more with CO than with
hypoxic hypoxia, since BP fell with the former, but
increased with the latter. Following carotid chemore-
ceptor resection, BP also fell with hypoxic hypoxia. In
another acute study, both mean arterial BP and TPR
fell in anesthetized paralyzed dogs given CO over 15 to
20 min (21). The depressant effects of CO on these pa-
rameters was far greater than that ofhypoxic hypoxia.
As before, these differences were eliminated by resec-
tion of the carotid bodies, suggesting their role in the
response to hypoxic hypoxia but not in that to CO hy-
poxia.
Many studies involving CO, however, report no
change, or an increase, in BP. For example, Gutierrez
et al. (23) failed to see changes in either mean systemic
or mean pulmonary BPs in anesthetized dogs at 50%
COHb, whether CO was administered by inhalation or
by IP injection. In addition, neither systemic nor pul-
monaryvascularresistancechanged significantlyinthat
study. No significant change was found by Cramlet et
al. (29) in left ventricular mean pressure in conscious
dogs acutely attaining 10, 20, and 30% COHb. Neither
Adams and his co-workers (28), examining left ventric-
ular pressure in awake dogs at 5 to 20% COHb over 30
min, nor Lillelei and his collaborators (18), measuring
arterial BP of dogs at 50% COHb over the same time
period, saw changes.
Humans. Chiodiandco-workers (14)foundthat sys-
tolic BP rose or remained steady, while diastolic values
fell in humans at COHb as high as 48%. The observa-
tions of others (75,76) also suggest decreased TPR in
CO poisoning. Peripheral vasodilation and pooling of
blood occurs in organs other than the skin in people
working at 25 to 33% COHb (40). It is suggested that
this contributes to slightly elevated core temperature
in carboxyhemoglobinemia. Acute CO poisonings in hu-
mans is reported to be accompanied by lability of BP,
including peripheral vasodilation; long-term CO expo-
sure often produces hypotension (41).
On the other hand, Stewart et al. (39) reported no
change in systolic or diastolic blood pressure in men at
0 to 15% COHb. Even during exercise at 18 to 20%
COHb, arterial BP in humans, as at rest, was not dif-
ferent from men in room air at the same activity level
(43). However, since Q increased with higher work in-
tensity in this tudy, calculated TPR decreased consid-
erably.
Chronic
Penney et al. (20) reported a sharp decline in both
systemic and pulmonary resistances in rats held at 38
to 42% COHb for 42 days. However, Lillehei et al. (18)
reported normal BP in dogs gradually acclimatized to
1000 ppm CO for 6 to 8 hr per day fora year. Likewise,
James et al. (52) saw no significant change in peak left
ventricular pressure and TPR in conscious goats main-
tained at 20% COHb for 2 weeks. There was no change
in BP in Cynomolgus monkeys after 8 months at 11.2%
COHb (53).
While Klausen et al. (56) found no changes in systolic
and diastolic BP in resting men maintained at 12%
COHb for 8 days, the former pressure increased and
the latter fell relative to working air controls when the
men inhaling CO also worked.
Even at rest, increases in femoral artery pressure
were seen in dogs inhaling CO (17), and the same oc-
curred in systolic, diastolic, and mean arterial BP and
right ventricular systolic pressure in anesthetized dogs
at 26.5 and 41.6% COHb (16). Modest increases in left
and right ventricular systolic pressure and mean aortic
pressure have been reported in rats held at 38 to 42%
COHb for 42 days (20). The BP ofrabbits was reported
to be higher following 100 ppm CO exposure for 2500
hr (55) and after inhalation of 1500 ppm CO for 3 hr
each day for many weeks (77). In the latter case, the
elevated BP failed to renormalize postexposure when
CO treatment exceeded 7 weeks.
It is clear, that as with HR, SV, and Q, there is wide
variability inthe BPresponse to CO in different species
and under various experimental conditions. Human
studies have generally failed to demonstrate systemic
hypotension with CO, while a number ofanimal studies
have. This difference may be, as with the other hemo-
dynamic parameters reviewed here, largely a function
ofthe lower COHb levels used in human studies; how-
ever, failure to show profound systemic hypotension in
man brings into question current explanations of CO
encephalopathy.
Generally, a COHb saturation above 20% is accom-
plishedby some fallinBPinmostspecies. Forexample,
in the recent study by Kanten et al. (19), mean arterial
BP fell 37 mm Hg as COHb increased from 0 to 38%.
At the same time, Q rose to 78% above controls mainly
through increased SV. Theseinvestigators suggestthat
depressed afterload contributes to SV augmentation.
They believe that hypotension results primarily from
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the direct local effect of CO producing peripheral vas-
cular dilation, as demonstrated by Coburn (60) in iso-
lated aorta.
Lahiri (78) found that most carotid body receptors
are not stimulated by moderate COHb saturation or
hypotension. He interpreted this to mean that the re-
ceptor tissue is not sensitive to hemoglobin-bound ox-
ygen; presumably, duetoanexceedinglyhighbloodflow
rate. On the other hand, these manipulations stimulate
aortic chemoreceptor activity, indicating hemoglobin-
bound oxygen was a stimulus there. Blood flow to the
aortic body is low and critical. A subsequent study con-
firmed this (79). Thus, the response to CO is different
from that to other hypoxic stimuli. The usual mecha-
nisms responsible for sensing hypoxia and initiating a
response fail, due to the nature ofCO-hemoglobin bind-
ing. The responses that occurarethose slowerreactions
to local hypoxia and are not as effective as the rapid
multiple responses triggered by hypoxic hypoxia.
Coronary and Cerebral Blood Flow
There is general agreement that vascular resistance
falls and blood flow increases in the coronary circulation
during carboxyhemoglobinemia. This presumably oc-
curs because ofthe great sensitivity ofthe myocardium
to hypoxemia, the depressed mixed venous P02 at the
coronary sinus (17), decreased arteriovenous oxygen
content difference across the coronary circulation, and
the fall in myocardial oxygen consumption (17,28).
For example, Ayres et al. (17) reported increases in
coronary blood flow in both humans and dogs over a
wide range of COHb saturation. In the human studies,
flowincreased when COHb was raised tobetween 5 and
10%. Increased coronary blood flow also results from
cigarette smoking in normal men (80), but this may not
occur in men with coronary artery disease (81). Adams
et al. (28), using conscious dogs, saw a 13% increase in
coronary blood flow at 4% COHb, and a 54% increase
at 20% COHb. They suggest a linearrelationship exists
between COHb and blood flow.
Young and Stone (30) found substantial increases in
coronary blood flow and decreases in diastolic coronary
resistance with no change in myocardial oxygen con-
sumption in chronicallyinstrumented, conscious dogs at
30% COHb. While this occurred in paced animals, in-
dicating the flow increase was independent of HR, it
was attenuated by blockage with propranolol and atro-
pine. They suggest that coronary vasodilation observed
with reduced arterial oxygen saturation is mediated
through a neurogenic mechanism. Scharf et al. (82), on
the other hand, used isolated perfused dog hearts to
examine the effects ofboth CO and hypoxic hypoxia in
decreasing coronary vascular resistance. At constant
coronary flow with 13-blockade, vascular resistance de-
creased more with CO than with hypoxic hypoxia.
More recently, McGrath and collaborators (83-85),
using a bloodless, isolated perfused heart preparation,
demonstrated that CO results in greater coronary va-
sodilation than nitrogen anoxia, strengthening the con-
tention that CO has a direct effect on vascular smooth
muscle discrete from an anoxic one.
Not only does CO appear to increase coronary blood
flow globally, it also increases the number ofopen cap-
illary beds (72). The presence of CO, however, leaves
the endocardiumrelativelyunder-perfused ascompared
to the epicardium (16).
Increased cerebral blood flow (CBF) was observed in
anesthetized goats where COHb saturation increased
to 65% in 10 min. The investigators (86) saw 133 and
200% increases in CBF in anesthetized dogs when
COHb levels were raised to 30 and 51%, respectively.
These CBF levels were significantly greater than those
produced by cyanide. Koehler et al. (88,89) reported
greater CBF in unanesthetized newborn lambs and in
adult sheep exposed to CO hypoxia than in those ex-
posed to hypoxic hypoxia; suggesting this be a function
of the leftward shift of the oxyhemoglobin dissociation
curve that accompanies COHb. Their findings are con-
sistent with the results of Traystman and Fitzgerald
(74) ofagreater decreaseincerebralvascularresistance
with CO.
Myocardial Contractility
The first derivative of changing ventricular pressure
(dPldt) has been used by many investigators as one
index of contractility. Adams et al. (28) reported no
change in maximum dPldt in conscious dogs at 5 to 20%
COHb. However, using isolated perfused dog hearts
treated with CO, Schaf and co-workers (82) saw in-
creases indP/dtthatwere eliminated with ,B-adrenergic
blocking agents. In support of this, Cramlet et al. (29)
observed increases to dP/dtmax relative to air controls
in conscious dogs reaching 10 to 30% COHb. Penney et
al. (20), working with rats maintained at 40% COHb for
42 days, alsoreported elevated left ventriculardPldtmax
during the first 2 weeks relative to controls. Neverthe-
less, it is unclear to what extent increased dP/dt is sim-
ply the result of increased HR versus that resulting
from enhanced sympathetic drive and circulating cate-
cholamines.
Right ventricle and left ventricle dP/dtma,, rose 58%
and 41% above controls, respectively, in dogs acutely
inhaling smoke from burning charcoal and sawdust (26).
COHb reached 72%, whileP02 fell and PCO2 rose in that
study.
Stewart and his group (39), on the other hand, noted
no change in myocardial contractility as judged by pre-
ejection time in humans at 0 to 15% COHb, and James
et al. (52) drewthe same conclusion forthe left ventricle
ofconscious goats during 2 weeks at 20% COHb, based
on estimates of Vmax. Recently, left ventricle dPldtmaxc
has been reported to be unchanged in anesthetized rats
at COHb of 7% to 35-38% over 48 hr (19). Ingenito et
al. (90) suggested that CO may exert a direct negative
inotropic effect on the myocardium.
Heart Work
Few data exist on myocardial work during carboxy-
hemoglobinemia. In pentobarbital anesthetized rats
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maintained at38to42% COHbfor6weeks, meanstroke
power in the presence ofpolycythemia was almost half
that of controls (20). However, in a more recent study
using normocythemic rats anesthetized with chloralose-
urethan, strokeworkand strokepowerwereunchanged
over 48 hr at 7 to 38% COHb (19). In the latter case,
even though SV and HR rose, arterial BP, a major
contributor to work and power, fell.
Blood Volume
Total blood volume (BV) increases as another re-
sponse to chronic CO exposure, and serves to increase
cardiac preload. Forexample, Wilks and colleagues (91)
found a 52% increase in BV in dogs exposed to 800 to
1000 ppm CO for 6 to 8 hr daily for 20 weeks, while
plasma volume increased only 17%. Hence, most ofthe
volume increase was due to greater erythrocyte mass.
Zebro et al. (92) also reported a very large BV increase
in mice maintained at 74% COHb for more than two-
thirds of a 36-day CO exposure period; however, they
measured BV merely by draining the blood from sac-
rificed animals. Theodore and collaborators (49), in a
very long-term study, found a39% BV increase in mon-
keys and a 31% increase in dogs exposed to 355 ppm
COfor71days, followedby444ppmCOforanadditional
97 days. In the monkeys, this involved a 145% increase
in erythrocyte volume and a 6% decrease in plasma
volume. In the dogs, red cell volume increased 69%,
while plasma volume increased 19%.
BV increases within a few days in adult rats inhaling
500 ppm CO, reaching a value about 60% above controls
after42 days (Penney and Davidson, unpublished data).
This results from an increase in erythrocyte mass, with
nochange oraslight fallinplasmavolume, asinhypoxic
hypoxia (93). In rats exposed to incrementally increas-
ing CO concentrations (i.e., 250, 500, 750, and 1300
ppm), blood volume increases in a nearly linear fashion,
more than doubling at the highest CO level as the result
ofamorethanthreefoldincrease inerythrocyte volume.
Real hematocrit (no trapped plasma) rises from 49 to
74% (Penney et al., unpublished data).
In contrast, Ogawa et al. (94), in a short-term study,
noted that BV fell 20% after 30 min at 60% COHb,
mainlyduetoasharpreductioninplasmavolumecaused
by increased vascular permeability. This led to a 20%
rise in hematocrit. However, at a lower COHb (29%)
level, Syvertsen and Harris (95) saw no change in he-
matocrit until 72 hr after starting in dogs inhaling 195
ppm CO, in contrast to hypoxic hypoxia where hema-
tocrit rose almost immediately, suggesting the absence
ofsplenic contraction in CO hypoxia. Siggard-Anderson
et al. (96) found only slight or no change in plasma
volume in human subjects after 12 hr and 8 days ex-
posure to CO.
Conclusions
Wemight summarize the time-course ofthe response
to CO by drawing together the findings from one model
system with which considerable work has been done-
the rat (Fig. 1). Although much ofthe data have been
gathered under anesthesia, conscious data, where ob-
tainable, are confirmatory. Unfortunately, no other
comprehensive acute and long-term studies of CO poi-
soninghave beencarried outbyasingle laboratorywith
another species (e.g., dogs, in which the bulk of CO
work has been done). Presumably, the picture pre-
sented here is a fairly general one.
CO is taken up rapidly to an equilibrium blood sat-
uration (11,12). Increase in Q as the result ofincreases
in SV and HR occur early (e.g., minutes), at COHb
saturations of 10% or less (19). At the same time, ar-
terial BP and TPR are sharply depressed (70). Within
3 to 5 days, developing polycythemia is detectable
(50,51), at least at CO levels above a threshold value of
100 ppm (97), resulting in a gradually increasing BV.
While this improves oxygen-carrying capacity, tissue
oxygen delivery may remain impaired because CO in-
creases hemoglobin-oxygen affinity (98). Nonetheless,
elevated SV, HR, and Q subside, as a smaller contri-
bution by the latter to oxygen transport is required in
the presence of polycythemia. At the same time, how-
ever, increased blood viscosity, previously normal dur-
ing initial carboxyhemoglobinemia, contributes to rais-
ing stroke and minute work, especially at CO concen-
trations of 500 ppm and above, which greatly elevate
hematocrit. Increased viscosity acts in part to return
BP and TPR toward, but not to, normal. The lung vas-
culature, in fact, is very sensitive to increased blood
viscosity (93) and flow (99), probably resulting in some
degree of pulmonary hypertension.
Cardiomegaly (i.e., cardiac hypertrophy), although
not in the mainstream ofthis review, is part and parcel
of the chronic response to CO, and surely modifies the
heart's subsequent hemodynamic response to CO. It
develops in both ventricles and atria with the addition
of new myocardial constituents (97) and involves pri-
marily anincrease inlumen dimensionswith some small
increase in wall thickness ofthe ventricles (i.e., eccen-
tric hypertrophy) (100). While CO-induced cardiome-
galy is probably mainly a product ofincreased preload
(e.g., increased venous return, BV), enhanced sympa-
thetic drive and possibly viscosity- and flow-induced el-
evated afterload may have roles. Surely, a subtle in-
terplay exists between the hemodynamic responses to
CO which occur early, and the secondary acclimative
responses (e.g., polycythemia, increased BV, cardio-
megaly), such that adequate tissue oxygenation is sus-
tained, or at a minimum, improved over that in their
absence.
After 5 to 6 weeks of CO exposure, Q, SV, and HR
continue somewhat supranormal. Arterial BP and TPR
remain depressed, while stroke work and minute work
(i.e., power) are elevated. Rapid elimination of CO, ef-
fected by breathing room air, results in a number of
charges which persist for several weeks: TPR and BP
are elevated 52 and 40%, respectively, presumably be-
causeofhighbloodviscosityintheabsence ofperipheral
vasodilation. While Q returns to normal, SV is de-
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pressed, probably as the result of the increased after-
load. Tachycardia continues, providing normal output,
while stroke work and minute work rise to still higher
levels than earlier. The latterillustrates theimportance
ofvasodilation during chronic carboxyhemoglobinemia,
maintaining heart work at a far lower level than would
otherwise be the case with polycythemia present. The
polycythemia and cardiomegaly then gradually subside
over the following 20 to 30 days (51,101).
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